Beier D, Wilhelm H
Neurologische Universitätsklinik Tübingen, Zentrum für Neurologie, Abteilung Allergie--Neurologie.
Klin Monbl Augenheilkd. 2005 Sep;222(9):740-5. doi: 10.1055/s-2005-858463.
Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a chronic inflammatory disease of unknown origin that is morphologically characterized by a local fibrotic thickening of the dura mater with a sterile lymphocytic infiltrate. Patients usually present with chronic headache, ataxia and cranial nerve palsies. Because of the great diversity of symptoms and the fact that IHCP can be associated with many other disorders, there is often a long time between the occurrence of clinical features and making the diagnosis. During this time symptoms can further increase. In addition, this is the third case report describing bone involvement in this disorder.
In May 2000, a 51-year-old woman presented with reduced visual acuity on both eyes, complete palsies of the fourth and sixth cranial nerve, a partial palsy of the third cranial nerve and numbness and pain concerning the area of the fifth cranial nerve on the left side, painful eye movement on the left side, headache, and numbness and palsies on the left side of her body. Magnetic resonance imaging of the brain showed a focal gadolinium-enhanced small thickening of the dura mater close to the left hemisphere and a homogeneous bone thickening in the same area close to the thickened dura mater. Cerebrospinal fluid analysis revealed an elevated cell count (lymphocytic pleocytosis), routine blood counts and serum chemistry showed an elevated white blood count, an elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Therapy with corticosteroids resulted in a complete remission in November 2000 except for a persistent numbness of the left side of her face and body and reduced visual acuity on both sides. The following three years were characterized by repeated clinical deteriorations followed by a temporary increase of the daily steroid dose. Altogether, daily oral steroid therapy could slow down the progression of disease and improve the visual acuity when compared with the first examination.
Chronic headache, ataxia and cranial nerve palsies in combination with inflammation and dural thickening should call to mind idiopathic hypertrophic cranial pachymeningitis. In principle, every ophthalmological or neurological symptom can be associated with IHCP.
特发性肥厚性硬脑膜炎(IHCP)是一种病因不明的慢性炎症性疾病,其形态学特征为硬脑膜局部纤维化增厚伴无菌性淋巴细胞浸润。患者通常表现为慢性头痛、共济失调和颅神经麻痹。由于症状的多样性以及IHCP可与许多其他疾病相关,临床特征出现与诊断之间往往间隔较长时间。在此期间症状可能会进一步加重。此外,这是第三例描述该疾病骨受累情况的病例报告。
2000年5月,一名51岁女性出现双眼视力下降、第四和第六颅神经完全麻痹、第三颅神经部分麻痹以及左侧第五颅神经区域麻木和疼痛、左侧眼球运动疼痛、头痛,以及左侧身体麻木和麻痹。脑部磁共振成像显示靠近左半球的硬脑膜有局灶性钆增强小增厚,且在增厚硬脑膜同一区域有均匀的骨质增厚。脑脊液分析显示细胞计数升高(淋巴细胞增多),血常规和血清化学检查显示白细胞计数升高、C反应蛋白(CRP)和红细胞沉降率(ESR)升高。使用皮质类固醇治疗后,除左侧面部和身体持续麻木以及双眼视力下降外,于2000年11月实现完全缓解。接下来的三年中,病情反复恶化,随后每日类固醇剂量临时增加。总体而言,与首次检查相比,每日口服类固醇治疗可减缓疾病进展并提高视力。
慢性头痛、共济失调和颅神经麻痹,同时伴有炎症和硬脑膜增厚,应考虑特发性肥厚性硬脑膜炎。原则上,任何眼科或神经科症状都可能与IHCP相关。